Medical affairs in a digital-first world: Benefits and challenges
Pharmaceutical Technology
NOVEMBER 2, 2022
The pharmaceutical community has reached somewhat of a turning point as it commercialises a growing number of speciality medicines relying on complex new treatment pathways. Being able to address medical communities on multiple channels challenges the paradigm of the very rigid structure we are used to in medical affairs,” starts Ødum.
Let's personalize your content